PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/Leptin
Metabolic & Glycemic ControlAdipokine Signaling & Hypothalamic Satiety

Serum Leptin (Leptin)

Leptin is a peptide hormone synthesized by white adipose tissue that signals systemic energy sufficiency to hypothalamic POMC/CART neurons to suppress appetite and increase basal thermogenesis.

Standard Range0.5 - 13.8 ng/mL (Male), 1.1 - 27.5 ng/mL (Female)
Optimal Longevity2.0 - 6.0 ng/mL
Measurement Unitng/mL
Organ SystemAdipokine Signaling & Hypothalamic Satiety
Routine Panels:Adipokine ProfileMetabolic Longevity Panel

Standard vs. Optimal Reference Rangesng/mL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: ng/mL
ng/mL
Presets:
0 ng/mLOptimal Zone Target19 ng/mL
Optimal Longevity Zone(4 ng/mL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

0.5 - 13.8 ng/mL (Male), 1.1 - 27.5 ng/mL (Female)

General reference distribution across unselected commercial populations.

Optimal Longevity Target

2.0 - 6.0 ng/mL

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Binds the LepRb receptor in the arcuate nucleus, activating JAK2-STAT3 signaling. In obesity, chronic hyperleptinemia induces SOCS3 feedback inhibition, causing central leptin resistance.

Differential Diagnosis

Elevated Levels (Leptin High)

  • •Adipose hypertrophy / Central leptin resistance
  • •Severe obesity
  • •Chronic low-grade inflammation

Low Levels (Leptin Low)

  • •Congenital leptin deficiency (rare)
  • •Severe lipodystrophy
  • •Extreme leanness / Caloric restriction

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
The physiological homeostasis of Serum Leptin (Leptin) is governed by pancreatic islet beta-cell secretion, hepatic gluconeogenesis, skeletal muscle GLUT4 glucose transporter translocation, and peripheral insulin sensitivity. Cellular signal transduction occurs via the insulin receptor tyrosine kinase (IRTK), triggering phosphorylation of IRS-1 and IRS-2, which activates the phosphatidylinositol 3-kinase (PI3K)-Akt cascade and downregulates FOXO1 transcription factors. Impaired signaling causes systemic hyperinsulinemia, attenuated mitochondrial beta-oxidation, and accelerated hepatic de novo lipogenesis (DNL).
Longevity Risk Architecture & Epidemiology
Low circulating leptin in the presence of healthy body composition reflects preserved central leptin sensitivity, optimal lipid partitioning, and low inflammatory adipokine secretion.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Strict 10 to 12 hour overnight water-only fasting is mandatory for baseline metabolic quantification. Acute psychological stress, acute infectious illness, and sleep deprivation (<6 hours) transiently elevate cortisol and catecholamines, falsely elevating glycemic markers. For glucose and insulin testing, draw blood into sodium fluoride/potassium oxalate tubes or separate serum promptly within 30 minutes to prevent ongoing in vitro red blood cell glycolysis.

Reflexive Testing Protocol:

  • Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and HOMA-Beta calculations
  • Continuous Glucose Monitoring (CGM) 14-day wear to evaluate glycemic variability and postprandial excursions
  • Fasting C-Peptide and high-sensitivity Troponin/hs-CRP to differentiate insulin resistance from beta-cell exhaustion
  • Oral Glucose Tolerance Test (OGTT) with simultaneous 0, 30, 60, and 120-minute insulin assays
  • Abdominal ultrasound or FibroScan to evaluate hepatic steatosis and non-alcoholic fatty liver disease (MASLD)
Clinical Citations & Primary Literature (1)
  • [1]Leptin Signaling in Energy Homeostasis and Neuroendocrine Function - Cell Metabolism (2021). PMID: 34183819
Common Panels:Adipokine ProfileMetabolic Longevity Panel
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Leptin (Leptin) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

Serum Adiponectin
Adiponectin · > 12.0 μg/mL (Male), > 15.0 μg/mL (Female)
Fasting Serum Insulin
Fasting Insulin · 2.0 - 5.0 μIU/mL
Homeostatic Model Assessment of Insulin Resistance
HOMA-IR · < 1.0
PreviousSerum Fructosamine (Fructosamine)Metabolic & Glycemic ControlNextSerum Adiponectin (Adiponectin)Metabolic & Glycemic Control